News Leaflets
A leading news portal.

Hemgenix, World’s Most Expensive Drug, Approved by US FDA To Treat Hemophilia, Costs Over Rs 28 Crore per Dose

0 8

According to reports, the U.S. Food and Drug Administration recently approved Hemgenix, a new drug to treat hemophilia. Reportedly, manufacturer CSL Behring has set the price of the drug at $3.5 million per treatment, thereby making it the most expensive drug in the world. As per reports, the Hemgenix drug is a gene therapy to treat adults with hemophilia B. The hemophilia B is a genetic bleeding disorder due to which people are not able to produce a protein that is needed to create blood clots. About 1 in 40,000 people have the disease, most of whom are men. US FDA Lifts Hold on Bharat Biotech’s COVID-19 Vaccine Covaxin’s Clinical Trials in America.

FDA Approves Drug To Treat Hemophilia

(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user’s social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! News Leaflets is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.
Leave a comment